ARTHEx Biotech Delivers Multiple Presentations at IDMC-15 Highlighting Clinical Progress of ATX-01 and Mechanistic Insights for Myotonic Dystrophy Type 1 (DM1) and 2 (DM2)
PRNewsWire
·
2026-05-27
·
via The Tech Buzz - Press Releases
VALENCIA, Spain, May 27, 2026 /PRNewswire/ -- ARTHEx Biotech, a clinical-stage biotechnology company advancin…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。